Filing a patent application, especially in the biopharmaceutical sector, is often viewed positively by investors as it can protect and potentially create new revenue streams through proprietary technology or processes. For Aileron Therapeutics, this move could enhance its competitive edge and attract investor interest, likely leading to a positive short-term impact on its stock price.